Clinical Trial Update: Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated the safety and efficacy of Botulinum toxin Type A for neurogenic overactive bladder; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Overactive Bladder
• Overactive Bladder

Drugs mentioned

• OnabotulinumtoxinA (botulinum toxin type A)

Snippet

Sponsor: Allergan | Conditions: Overactive Bladder | Phase 3 | Status: COMPLETED | Results posted: 2011-10-17